Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Magnetic resonance imaging of hippocampal subfields in posttraumatic stress disorder.

Wang Z, Neylan TC, Mueller SG, Lenoci M, Truran D, Marmar CR, Weiner MW, Schuff N.

Arch Gen Psychiatry. 2010 Mar;67(3):296-303. doi: 10.1001/archgenpsychiatry.2009.205.

2.

Serum brain-derived neurotrophic factor in patients with trauma psychopathology.

Hauck S, Kapczinski F, Roesler R, de Moura Silveira E Jr, Magalhães PV, Kruel LR, Schestatsky SS, Ceitlin LH.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):459-62. doi: 10.1016/j.pnpbp.2010.01.010.

PMID:
20097247
3.

Duration of posttraumatic stress disorder predicts hippocampal grey matter loss.

Felmingham K, Williams LM, Whitford TJ, Falconer E, Kemp AH, Peduto A, Bryant RA.

Neuroreport. 2009 Oct 28;20(16):1402-6. doi: 10.1097/WNR.0b013e3283300fbc.

PMID:
19794316
4.

Antidepressants increase neural progenitor cells in the human hippocampus.

Boldrini M, Underwood MD, Hen R, Rosoklija GB, Dwork AJ, John Mann J, Arango V.

Neuropsychopharmacology. 2009 Oct;34(11):2376-89. doi: 10.1038/npp.2009.75.

5.

Serum levels of brain-derived neurotrophic factor in acute and posttraumatic stress disorder: a case report study.

Hauck S, Gomes F, Silveira Júnior Ede M, Almeida E, Possa M, Ceitlin LH.

Rev Bras Psiquiatr. 2009 Mar;31(1):48-51.

6.

Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder.

Dell'Osso L, Carmassi C, Del Debbio A, Catena Dell'Osso M, Bianchi C, da Pozzo E, Origlia N, Domenici L, Massimetti G, Marazziti D, Piccinni A.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):899-902. doi: 10.1016/j.pnpbp.2009.04.018.

PMID:
19409951
7.

The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression.

Küçükibrahimoğlu E, Saygin MZ, Calişkan M, Kaplan OK, Unsal C, Gören MZ.

Eur J Clin Pharmacol. 2009 Jun;65(6):571-7. doi: 10.1007/s00228-009-0650-7.

PMID:
19373461
8.

Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?

Vinogradov S, Fisher M, Holland C, Shelly W, Wolkowitz O, Mellon SH.

Biol Psychiatry. 2009 Sep 15;66(6):549-53. doi: 10.1016/j.biopsych.2009.02.017.

9.

Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review.

Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, Marmar CR, Figueira I.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):169-80. doi: 10.1016/j.pnpbp.2008.12.004. Review.

10.

Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward.

Graham DL, Krishnan V, Larson EB, Graham A, Edwards S, Bachtell RK, Simmons D, Gent LM, Berton O, Bolanos CA, DiLeone RJ, Parada LF, Nestler EJ, Self DW.

Biol Psychiatry. 2009 Apr 15;65(8):696-701. doi: 10.1016/j.biopsych.2008.09.032.

11.

Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences.

Piccinni A, Marazziti D, Del Debbio A, Bianchi C, Roncaglia I, Mannari C, Origlia N, Catena Dell'Osso M, Massimetti G, Domenici L, Dell'Osso L.

Chronobiol Int. 2008 Sep;25(5):819-26. doi: 10.1080/07420520802387773.

PMID:
18780207
12.

Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons.

Bachis A, Mallei A, Cruz MI, Wellstein A, Mocchetti I.

Neuropharmacology. 2008 Dec;55(7):1114-20. doi: 10.1016/j.neuropharm.2008.07.014.

13.

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications.

Sen S, Duman R, Sanacora G.

Biol Psychiatry. 2008 Sep 15;64(6):527-32. doi: 10.1016/j.biopsych.2008.05.005.

14.

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.

Matrisciano F, Bonaccorso S, Ricciardi A, Scaccianoce S, Panaccione I, Wang L, Ruberto A, Tatarelli R, Nicoletti F, Girardi P, Shelton RC.

J Psychiatr Res. 2009 Jan;43(3):247-54. doi: 10.1016/j.jpsychires.2008.03.014.

15.

Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm.

Begliuomini S, Lenzi E, Ninni F, Casarosa E, Merlini S, Pluchino N, Valentino V, Luisi S, Luisi M, Genazzani AR.

J Endocrinol. 2008 May;197(2):429-35. doi: 10.1677/JOE-07-0376.

16.

Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.

Grassi-Oliveira R, Stein LM, Lopes RP, Teixeira AL, Bauer ME.

Biol Psychiatry. 2008 Aug 15;64(4):281-5. doi: 10.1016/j.biopsych.2008.02.023.

PMID:
18406398
17.

Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.

Hellweg R, Ziegenhorn A, Heuser I, Deuschle M.

Pharmacopsychiatry. 2008 Mar;41(2):66-71. doi: 10.1055/s-2007-1004594.

PMID:
18311687
18.

Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder.

Bryant RA, Felmingham K, Kemp A, Das P, Hughes G, Peduto A, Williams L.

Psychol Med. 2008 Apr;38(4):555-61.

PMID:
18005496
19.

Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy.

Adachi M, Barrot M, Autry AE, Theobald D, Monteggia LM.

Biol Psychiatry. 2008 Apr 1;63(7):642-9.

20.

Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology.

Kauer-Sant'Anna M, Tramontina J, Andreazza AC, Cereser K, da Costa S, Santin A, Yatham LN, Kapczinski F.

Bipolar Disord. 2007 Jun;9 Suppl 1:128-35.

PMID:
17543031
Items per page

Supplemental Content

Support Center